Atropos Health’s platform, including GENEVA OS™ and the Atropos Evidence™ Network Launches AI Model for Precision Medicine at Scale

Today, we’re pleased to announce the deployment of AI models to clinicians for the identification of patients living with undiagnosed conditions. These models–trained, developed, and tested using real-world data (RWD)–are created by medical doctors, epidemiologists, statisticians, and Masters/PhD-level personnel to reduce the time from initial symptom to testing, diagnosis and treatment at the point of care. More models will be delivered throughout the year.

Deployed via members of the Atropos Evidence Network, membership benefits include the ability to leverage the network to deliver AI models to clinicians. Atropos Health is collaborating with Arcadia to help leading healthcare organizations deliver the latest care protocols and advanced precision medicine at scale. The partnership enables healthcare providers to accelerate clinical decision-making with actionable, AI-powered insights at the point of care using the combination of real-world evidence (RWE) and longitudinal patient records to improve outcomes and drive high-value, low-cost care. Life sciences companies are also engaged with Atropos Health on leveraging AI for precision medicine.

Read the full release